HCG and Male Fertility on Steroids: How to Preserve Sperm Count While Running a Cycle in the UK

Most UK bodybuilders assume that fertility and steroid use are mutually exclusive: you either run cycles or you have children, but not both at the same time. This is wrong. A 2025 retrospective study from a Dutch harm reduction clinic, published in F&S Reports, demonstrated that HCG restores spermatogenesis in men actively using androgens who refused to discontinue. The study found that consistent HCG administration normalised intratesticular testosterone and restored measurable sperm counts in the majority of participants, even while they continued running steroid cycles. Available from Intex Pharma UK, Intex Pharma HCG 5000IU is the compound that makes fertility preservation on steroids pharmacologically possible, and this guide explains the full mechanism, the clinical evidence and the practical protocol.

This is not the standard “HCG for testicular atrophy” article. The existing guide on testicular atrophy prevention during steroid cycles covers testicular size maintenance. This guide goes further: it covers the preservation of actual fertility (sperm production) during and after steroid use, which is a fundamentally different clinical objective that requires a different understanding of the underlying physiology.

How Steroids Destroy Fertility: The Mechanism Most Users Do Not Understand

When you inject exogenous testosterone or any anabolic steroid, the elevated androgen levels signal the hypothalamus to suppress gonadotropin-releasing hormone (GnRH). Reduced GnRH output causes the pituitary gland to suppress both luteinising hormone (LH) and follicle-stimulating hormone (FSH). LH stimulates the Leydig cells in the testes to produce testosterone. FSH stimulates the Sertoli cells to support spermatogenesis. When both are suppressed by exogenous androgens, two things happen simultaneously: intratesticular testosterone (ITT) collapses, and spermatogenesis slows dramatically or stops entirely.

The critical detail is that the testosterone your testes produce (intratesticular testosterone) exists at concentrations 50 to 100 times higher than serum testosterone. Even when your blood testosterone is supraphysiological from injecting 500mg per week, your intratesticular testosterone can be near zero because the Leydig cells have stopped producing it. This intratesticular testosterone is the specific substrate that Sertoli cells require to support sperm production. Serum testosterone, regardless of how high it is, cannot substitute for intratesticular testosterone because it does not reach the seminiferous tubules at the concentration required for spermatogenesis.

This is why testosterone has been investigated as a male contraceptive. Supraphysiological doses of exogenous testosterone reliably suppress spermatogenesis to azoospermia (zero sperm count) or severe oligospermia (very low sperm count) in the majority of men within 3 to 6 months. For bodybuilders who are not thinking about children, this suppression is an unnoticed side effect. For those who want families, it is a crisis that could have been prevented with concurrent HCG use.

How HCG Preserves Fertility: Intratesticular Testosterone Rescue

HCG (human chorionic gonadotropin) is structurally and functionally analogous to LH. When injected, it binds to the same LH/CG receptors on Leydig cells that natural LH would bind to, stimulating them to produce testosterone. This intratesticular testosterone production occurs even when the pituitary’s own LH output is completely suppressed by exogenous androgens. HCG effectively bypasses the suppressed HPTA and directly tells the Leydig cells to keep working.

When intratesticular testosterone is maintained at adequate levels by HCG, the Sertoli cells continue to receive the androgenic signal they need to support spermatogenesis. The spermatogenic machinery does not shut down. Sperm production continues, albeit at a reduced rate compared to a non-suppressed state, but critically it continues rather than stopping entirely. Hochu et al. (2025) in Translational Andrology and Urology reviewed the evidence and confirmed that concomitant HCG with exogenous testosterone sustains intratesticular testosterone and spermatogenesis, with multiple studies demonstrating maintained sperm production even with full gonadotropin suppression from TRT.

The 2025 Dutch Harm Reduction Study: HCG Works Even Without Stopping Androgens

The most relevant clinical data for UK steroid users comes from a 2025 retrospective analysis of a harm reduction clinic in the Netherlands, published in F&S Reports. Nineteen men who had been using non-prescribed androgens for at least three months were treated with HCG without ceasing androgen use. The researchers respected the athletes’ decision to continue steroid use and focused on fertility restoration as a concurrent intervention.

The key findings were significant for the bodybuilding population. HCG administration restored measurable sperm counts (total motile sperm count, TMSC) in the majority of participants. The HCG dose itself did not significantly influence the degree of improvement, which the researchers interpreted as evidence that even minimal HCG doses are sufficient to normalise intratesticular testosterone concentrations. Once those concentrations are normalised, higher HCG doses produce diminishing returns for spermatogenesis because the testes already have the androgen substrate they need. The study concluded that consistent HCG administration matters more than the specific dose.

HCG Fertility Preservation Protocol for UK Steroid Users

The protocol below is designed specifically for UK bodybuilders who want to maintain the option of fatherhood while running steroid cycles. It differs from a standard “HCG for testicular size” protocol in two important ways: the dosing frequency is higher (to maintain consistent intratesticular testosterone rather than just preventing atrophy), and the protocol includes fertility monitoring through semen analysis rather than relying solely on bloodwork.

Reconstitution of Intex Pharma HCG 5000IU for Fertility Dosing

HCG is supplied as a lyophilised powder that requires reconstitution with bacteriostatic water before injection. The volume of water you add determines the concentration, which determines how many units you draw on your insulin syringe for each dose.

The 5ml reconstitution is recommended for fertility dosing because it produces the easiest measurement on a U-100 insulin syringe: 250IU equals exactly 25 units, and 500IU equals 50 units. This minimises dosing errors that could accumulate across weeks of frequent injection. Store reconstituted HCG in the refrigerator at 2 to 8°C and use within 30 days. HCG is more fragile than testosterone or peptides; do not freeze reconstituted solution and do not leave it at room temperature.

When HCG Alone Is Not Enough: The Role of FSH

HCG replaces LH activity but does not replace FSH activity. LH (via HCG) stimulates Leydig cells to produce intratesticular testosterone. FSH directly stimulates Sertoli cells to support the spermatogenic process. While intratesticular testosterone alone is sufficient to maintain some degree of spermatogenesis in most men, some individuals, particularly those with long-duration steroid use (blast and cruise for years) or those with pre-existing borderline fertility, may need FSH supplementation alongside HCG to achieve sperm counts adequate for conception.

Recombinant FSH (such as Gonal-F) at 75 to 150IU three times per week, added to the HCG protocol, provides the dual gonadotropin stimulation that fully mimics the natural hormonal environment of the testes. This combination is the standard clinical approach for treating male infertility in hypogonadotropic hypogonadism and can be applied to steroid-induced gonadotropin suppression using the same pharmacological logic. The addition of FSH is typically guided by semen analysis results: if HCG alone maintains a sperm count above 5 million per ml, FSH may not be necessary. If sperm count remains at zero or severe oligospermia despite 3 months of consistent HCG, FSH addition is the next step.

Fertility Monitoring: Semen Analysis for UK Steroid Users

Bloodwork alone does not confirm fertility. LH and FSH levels on bloodwork will be suppressed while running steroids regardless of HCG use (because the exogenous androgens suppress the pituitary, and HCG bypasses the pituitary entirely). The only way to confirm that spermatogenesis is actually continuing is a semen analysis.

Common Mistakes That Compromise Fertility Despite HCG Use

Starting HCG too late. The most damaging mistake is running multiple steroid cycles without HCG and then trying to restore fertility after years of complete gonadotropin suppression. Leydig cells that have been inactive for years may respond poorly to HCG due to prolonged atrophy. Starting HCG from the very first steroid cycle maintains Leydig cell function continuously, making fertility preservation far more reliable than attempted restoration.

Using HCG only during PCT. Reserving HCG for the PCT window means the testes have been completely suppressed for 12 to 16 weeks before receiving any gonadotropin stimulation. During that suppressed period, intratesticular testosterone was near zero and spermatogenesis was shut down or severely impaired. The 2025 Dutch study specifically demonstrated that concurrent HCG use during androgen exposure is what preserves fertility. PCT-only HCG attempts recovery, not preservation, and recovery is slower and less complete.

Dosing too high. HCG at doses above 1,000IU per injection stimulates significant intratesticular aromatase activity, converting the HCG-produced testosterone into oestradiol inside the testes. This oestradiol production occurs in a compartment that aromatase inhibitors do not fully reach. High-dose HCG produces diminishing returns for spermatogenesis while increasing oestrogen-related side effects. The clinical data supports 250 to 500IU as the optimal range for fertility preservation: sufficient to maintain intratesticular testosterone without excessive oestradiol conversion. For a detailed explanation of how HCG raises oestradiol and how to manage it, see the full guide on HCG and oestradiol management during a steroid cycle.

Not monitoring with semen analysis. Bloodwork shows hormones. Semen analysis shows fertility. These are not interchangeable. A user running HCG with perfect bloodwork can still have azoospermia if the HCG dose, frequency or individual response is not sufficient to maintain spermatogenesis. The only way to know is to test.

Recovery Timeline: How Long Does Fertility Take to Return After Steroids?

Spermatogenesis takes approximately 74 days from stem cell to mature sperm. Even after gonadotropin support is restored (either through HCG during use or HPTA recovery after cessation), it takes a minimum of 3 months before the new cohort of sperm completes development and appears in the ejaculate. Users who ran HCG throughout their cycle have a significant head start because spermatogenesis was never fully shut down; recovery is faster because there was less to recover from.

The difference between “HCG throughout” and “no HCG” is stark. Running Intex Pharma HCG 5000IU from the first injection of your first cycle is the single most impactful decision you can make for your long-term fertility. The cost is approximately £7 to £13 per week depending on the protocol. The cost of IVF in the UK if fertility does not recover naturally starts at £4,000 to £5,000 per cycle, with no guarantee of success. For general pre-cycle bloodwork guidance and the full PCT protocol with HCG and Clomid, follow the linked guides.

HCG and Fertility on Steroids: Frequently Asked Questions